Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Randomised Controlled Trial of an Artificial Intelligence Self Harm Application

NCT06019663 is registered in ClinicalTrials.gov with Pakistan Institute of Living and Learning as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06019663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Randomised Controlled Trial of an Artificial Intelligence Self Harm Application
Lead sponsor
Pakistan Institute of Living and Learning
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2024
Completion date
December 30, 2025
Enrollment
312 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

self-harm, suicide